Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 10213-10221

  Matsuo, Eiko ^a   Celma, Cristina C P ^a   Boyce, Mark ^a   Viarouge, Cyril ^b   Sailleau, Corinne ^b   Dubois, Eric ^c   Bréard, Emmanuel ^b   Thiéry, Richard ^c   Zientara, Stéphan ^b   Roy, Polly ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^c FRENCH AGENCY FOR FOOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLUETONGUE ORBIVIRUS VACCINE; BTVD2; BTVE1; CAPSID PROTEIN; DIFFERENTIATING INFECTED FROM VACCINATED ANIMAL VACCINE; DIVA VACCINE; INACTIVATED VACCINE; LIVE VACCINE; PROTEIN VP2; PROTEIN VP5; PROTEIN VP6; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BLUETONGUE ORBIVIRUS; CELL LINE; CONTROLLED STUDY; DISABLED INFECTIOUS SINGLE CYCLE STRAIN; FEMALE; GENE DELETION; GENETIC PROCEDURES; GENETIC REASSORTMENT; IMMUNITY; MALE; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHEEP; VIROGENESIS; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; CELL CULTURE TECHNIQUES; DEFECTIVE VIRUSES; FEMALE; MALE; REASSORTANT VIRUSES; SHEEP; VIRAL VACCINES; VIREMIA;

ANIMALIA; BLUETONGUE VIRUS; MAMMALIA; MIRIDAE; OVIS ARIES; REPLICATION DEFECTIVE VIRUSES;

EID: 80054004039     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05412-11     Document Type: Article

References (38)

1. Boone, J. D., et al. 2007. Recombinant canarypox virus vaccine coexpressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine 25:672-678.
2. Boyce, M., C. C. Celma, and P. Roy. 2008. Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts. J. Virol. 82:8339-8348.
3. Boyce, M., and P. Roy. 2007. Recovery of infectious bluetongue virus from RNA. J. Virol. 81:2179-2186.
4. Boyce, M., J. Wehrfritz, R. Noad, and P. Roy. 2004. Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity. J. Virol. 78:3994-4002.
5. Castrucci, M. R., P. Bilsel, and Y. Kawaoka. 1992. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J. Virol. 66:4647-4653.
6. Celma, C. C., and P. Roy. 2009. A viral nonstructural protein regulates bluetongue virus trafficking and release. J. Virol. 83:6806-6816.
7. Elbers, A. R., et al. 2008. Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands. Prev. Vet. Med. 87:31-40.
8. Forzan, M., M. Marsh, and P. Roy. 2007. Bluetongue virus entry into cells. J. Virol. 81:4819-4827.
9. French, T. J., J. J. A. Marshall, and P. Roy. 1990. Assembly of doubleshelled, viruslike particles of bluetongue virus by the simultaneous expression of four structure proteins. J. Virol. 64:5695-5700.
10. Gloster, J., P. S. Mellor, A. J. Manning, H. N. Webster, and M. C. Hort. 2007. Assessing the risk of windborne spread of bluetongue in the 2006 outbreak of disease in northern Europe. Vet. Rec. 160:54-56.
11. Gonzalez, J. M., et al. 2010. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. Vet. Rec. 166:757-758.
12. Halfmann, P., et al. 2009. Replication-deficient Ebolavirus as a vaccine candidate. J. Virol. 83:3810-3815.
13. Huismans, H., N. T. van der Walt, M. Cloete, and B. J. Erasmus. 1987. Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology 157:172-179.
14. Inumaru, S., and P. Roy. 1987. Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology 157:472-479.
15. Maan, S., N. S. Maan, N. Ross-smith, et al. 2008. Sequence analysis of bluetongue virus serotype 8 from the Netherlands 2006 and comparison to other European strains. Virology 377:308-318.
16. Marshall, J. J. A., and P. Roy. 1990. High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection. Virus Res. 15:189-195.
17. Matsuo, E., and P. Roy. 2009. Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation. J. Virol. 83:8842-8848.
18. Mertens, P. P., J. N. Burroughs, and J. Anderson. 1987. Purification and properties of virus particles, infectious subviral particles, and cores of bluetongue virus serotypes 1 and 4. Virology 157:375-386.
19. Mintiens, K., et al. 2008. Possible routes of introduction of bluetongue virus serotype 8 into the epicentre of the 2006 epidemic in northwestern Europe. Prev. Vet. Med. 87:131-144.
20. Osburn, B. I. 1994. The impact of bluetongue virus on reproduction. Comp. Immunol. Microbiol. Infect. Dis. 17:189-196.
21. Perrin, A., et al. 2007. Recombinant capripoxviruses expressing proteins of bluetongue virus: evaluation of immune responses and protection in small ruminants. Vaccine 25:6774-6783.
22. Purse, B. V., et al. 2005. Climate change and the recent emergence of bluetongue in Europe. Nat. Rev. Microbiol. 3:171-181.
23. Reynolds, E. S. 1963. The use of lead citrate at high pH as an electronopaque stain in electron microscopy. J. Cell Biol. 17:208-212.
24. Rimmelzwaan, G. F., et al. 2011. Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies. Vaccine 29:3424-3430.
25. Roy, P. 2008. Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication. Cell Biochem. Biophys. 50:143-157.
26. Roy, P. 1996. Orbivirus structure and assembly. Virology 216:1-11.
27. Roy, P. 2007. Orbiviruses and their replication, p. 1975-1997. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 5th ed., vol. 2. Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
28. Roy, P., D. H. Bishop, H. LeBlois, and B. J. Erasmus. 1994. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine 12:805-811.
29. Roy, P., M. Boyce, and R. Noad. 2009. Prospects for improved bluetongue vaccines. Nat. Rev. Microbiol. 7:120-128.
30. Roy, P., T. French, and B. J. Erasmus. 1992. Protective efficacy of virus-like particles for bluetongue disease. Vaccine 10:28-32.
31. Roy, P., J. J. Marshall, and T. J. French. 1990. Structure of the bluetongue virus genome and its encoded proteins. Curr. Top. Microbiol. Immunol. 162:43-87.
32. Roy, P., T. Urakawa, A. A. Van Dijk, and B. J. Erasmus. 1990. Recombinant virus vaccine for bluetongue disease in sheep. J. Virol. 64:1998-2003.
33. Stewart, M., et al. 2010. Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus. Vaccine 28:3047-3054.
34. Toussaint, J. F., C. Sailleau, E. Breard, S. Zientara, and K. De Clercq. 2007. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J. Virol. Methods 140:115-123.
35. van der Walt, N. T. 1980. A haemagglutination and haemagglutination inhibition test for bluetongue virus. Onderstepoort J. Vet. Res. 47:113-117.
36. Van Dijk, A. A., and H. Huismans. 1988. In vitro transcription and translation of bluetongue virus mRNA. J. Gen. Virol. 69(Pt. 3):573-581.
37. Verwoerd, D. W. 1969. Purification and characterization of bluetongue virus. Virology 38:203-212.
38. Weiner, M. P., et al. 1994. Site-directed mutagenesis of double-stranded DNA by the PCR. Gene 151:119-123.